High‐dose cytarabine (24 g/m2) in combination with idarubicin ( HiDAC ‐3) results in high first‐cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia
Year: 2012
Type: article
Study design: Observational Study
Source: Internal Medicine Journal
Authors: M. Low, D. Lee, J. Coutsouvelis, S. Patil, S. Opat, P. Walker, A. Schwarer, H. Salem, S. Avery, A. Spencer, A. Wei
Institutions: The Alfred Hospital, Alfred Health, Monash University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2133124692